Pharmacologic Perspectives of Functional Selectivity by the Angiotensin II Type 1 Receptor
Authors:
- Gitte Lund ChristensenGCGitte Lund Christensen
- Jakob Lerche HansenJHJakob Lerche Hansen
- 1 November 2008
- journal article
- review article
- Published by Elsevier in Trends in Cardiovascular Medicine
- Vol. 18 (8) , 305-312
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Molecular determinants of angiotensin II type 1 receptor functional selectivityJournal of Molecular and Cellular Cardiology, 2009
- β-Arrestin-mediated Signaling Regulates Protein SynthesisJournal of Biological Chemistry, 2008
- Differential Extracellular Signal‐Regulated Kinases 1 and 2 Activation by the Angiotensin Type 1 Receptor Supports Distinct Phenotypes of Cardiac MyocytesBasic & Clinical Pharmacology & Toxicology, 2007
- The Angiotensin Type 1 Receptor Activates Extracellular Signal‐Regulated Kinases 1 and 2 by G Protein‐Dependent and ‐Independent Pathways in Cardiac Myocytes and Langendorff‐Perfused HeartsBasic & Clinical Pharmacology & Toxicology, 2007
- Cardiac Myocyte Cell Cycle Control in Development, Disease, and RegenerationPhysiological Reviews, 2007
- Divergent Behavioral Roles of Angiotensin Receptor Intracellular Signaling CascadesEndocrinology, 2005
- β-Arrestin 1 and Gαq/11 Coordinately Activate RhoA and Stress Fiber Formation following Receptor StimulationJournal of Biological Chemistry, 2005
- Differential Kinetic and Spatial Patterns of β-Arrestin and G Protein-mediated ERK Activation by the Angiotensin II ReceptorJournal of Biological Chemistry, 2004
- Tyrosine Kinase Activation by the Angiotensin II Receptor in the Absence of Calcium SignalingJournal of Biological Chemistry, 2001
- Transgenic Gαq overexpression induces cardiac contractile failure in miceProceedings of the National Academy of Sciences, 1997